Fresenius | FRE - Capital Ordinário

Preço das Ações
40.25
Mudança Diária
-0.46 -1.13%
Mensal
-9.57%
Anual
1.00%
Q2 Previsão
39.19




Capital Ordinário Alterar Data
Akzo Nobel EUR 171.31M 200K 2026-03
Alcon AG USD 487.4M 7.2M 2025-12
AstraZeneca USD 1.55B 206K 2025-12
BASF EUR 892.52M 249.48M 2025-09
Bayer EUR 982.42M 0 2025-12
Beiersdorf EUR 218.92M 1.29M 2025-12
DaVita Healthcare Partners USD 68.55M 2.43M 2025-12
Demant DKK 210.9M 5.18M 2025-12
E.ON EUR 2.61B 1.21M 2025-12
Essilor EUR 463.05M 1.9M 2025-12
Fresenius EUR 563.24M 0 2025-09
Fresenius Medical Care EUR 279.29M 10.56M 2025-12
Getinge SEK 136M 0 2024-12
Givaudan CHF 9.23M 0 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GN Store Nord DKK 145.61M 458.39M 2025-09
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2025-12
Novartis USD 1.91B 10.64M 2025-12
Philips EUR 951.29M 310K 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
RWE EUR 713.56M 12.52M 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Smith & Nephew USD 875.96M 1.61M 2025-12